Pfizer - International Biopharmaceutical Industry

news

Moderna says vaccine protective through six months, but warns boosters needed this fall

Like Pfizer, Moderna is pressing the case for booster shots, although public health officials and experts have not yet agreed on when an additional dose would be need...

13 August 2021 news boosters | coronavirus

Continue Reading →

news

Pfizer’s fast progress shines spotlight on an emerging vaccine race

Drugmakers have laboured for decades to successfully develop a vaccine to protect infants and older people against infections of a common pathogen called respiratory ...

5 August 2021 news drugmakers | GlaxoSmithKline

Continue Reading →

news

Pfizer Expands Investment in Biotech through Pfizer Ventures

Company will spend $600 million on emerging/growth enterprises, with a focus on neuroscience. Pfizer Ventures, the venture capital arm of Pfizer, Inc, was founded in...

15 June 2018 news Biotech | expands

Continue Reading →

news

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

BIO hits its goal Three days into the BIO International convention, the industry group touted breaking the G...

8 June 2018 news BIO | BIO18

Continue Reading →

news

Pfizer Receives CRL for Biosimilar to Roche’s Herceptin

On April 23, 2018, Pfizer announced that it received a complete response letter (CRL) from FDA in response to the biologics license application (BLA) for the company’...

1 May 2018 news Biosimilar | CRL

Continue Reading →

Current Edition

Upcoming Events

Advertisement

Moderna says vaccine protective through six months, but warns boosters needed this fall

Pfizer’s fast progress shines spotlight on an emerging vaccine race

Pfizer Expands Investment in Biotech through Pfizer Ventures

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

Pfizer Receives CRL for Biosimilar to Roche’s Herceptin

International Biopharmaceutical Industry